Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods

Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3276-3289. doi: 10.1007/s00259-023-06279-0. Epub 2023 Jun 10.

Abstract

Purpose: Amyloid positron emission tomography (PET) with [18F]florbetaben (FBB) is an established tool for detecting Aβ deposition in the brain in vivo based on visual assessment of PET scans. Quantitative measures are commonly used in the research context and allow continuous measurement of amyloid burden. The aim of this study was to demonstrate the robustness of FBB PET quantification.

Methods: This is a retrospective analysis of FBB PET images from 589 subjects. PET scans were quantified with 15 analytical methods using nine software packages (MIMneuro, Hermes BRASS, Neurocloud, Neurology Toolkit, statistical parametric mapping (SPM8), PMOD Neuro, CapAIBL, non-negative matrix factorization (NMF), AmyloidIQ) that used several metrics to estimate Aβ load (SUVR, centiloid, amyloid load, and amyloid index). Six analytical methods reported centiloid (MIMneuro, standard centiloid, Neurology Toolkit, SPM8 (PET only), CapAIBL, NMF). All results were quality controlled.

Results: The mean sensitivity, specificity, and accuracy were 96.1 ± 1.6%, 96.9 ± 1.0%, and 96.4 ± 1.1%, respectively, for all quantitative methods tested when compared to histopathology, where available. The mean percentage of agreement between binary quantitative assessment across all 15 methods and visual majority assessment was 92.4 ± 1.5%. Assessments of reliability, correlation analyses, and comparisons across software packages showed excellent performance and consistent results between analytical methods.

Conclusion: This study demonstrated that quantitative methods using both CE marked software and other widely available processing tools provided comparable results to visual assessments of FBB PET scans. Software quantification methods, such as centiloid analysis, can complement visual assessment of FBB PET images and could be used in the future for identification of early amyloid deposition, monitoring disease progression and treatment effectiveness.

Keywords: Alzheimer’s disease; Amyloid-beta; Centiloid; Florbetaben; Mild cognitive impairment; Quantification.

MeSH terms

  • Alzheimer Disease* / diagnostic imaging
  • Alzheimer Disease* / pathology
  • Amyloid
  • Amyloid beta-Peptides* / metabolism
  • Aniline Compounds
  • Brain / metabolism
  • Humans
  • Image Processing, Computer-Assisted / methods
  • Positron-Emission Tomography / methods
  • Reproducibility of Results
  • Retrospective Studies
  • Software

Substances

  • 4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
  • Amyloid beta-Peptides
  • Aniline Compounds
  • Amyloid